Natixis’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$21.4K | – | 1072 |
|
|
2024
Q4 | $21.4K | Buy |
+200
| New | +$21.4K | ﹤0.01% | 919 |
|
|
2021
Q2 | – | Sell |
-17,793
| Closed | -$1.69M | – | 906 |
|
|
2021
Q1 | $1.69M | Buy |
+17,793
| New | +$1.69M | 0.01% | 735 |
|
|
2019
Q3 | – | Sell |
-8,930
| Closed | -$636K | – | 876 |
|
|
2019
Q2 | $636K | Buy |
+8,930
| New | +$636K | ﹤0.01% | 582 |
|